Scopolamine in Bipolar Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions
Bipolar Disorder Depression
Interventions
OTHER

Placebo / Saline

The placebo group will receive a 100ml infusion of saline at 4 visits during the study

DRUG

Scopolamine

The treatment group will receive a 100ml infusion of Scopolamine ( dose 4μg/kg) at 4 visits during the study

Trial Locations (1)

H91 YR71

University Hospital Galway, Galway

Sponsors
All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

collaborator

National University of Ireland, Galway, Ireland

OTHER

collaborator

HRB Clinical Research Facility Galway

OTHER

collaborator

University College Hospital Galway

OTHER

lead

Dr. Brian Hallahan

OTHER

NCT04211961 - Scopolamine in Bipolar Depression | Biotech Hunter | Biotech Hunter